Trials / Sponsors / Yanbing Li
Yanbing Li
Academic / Other · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Type 2 Diabetes | Phase 4 | 2026-03-15 |
| Not Yet Recruiting | Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes Type 2 Diabetes | — | 2025-10-01 |
| Unknown | Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect, 128 Patients Were Randomly Assigned 1:1 | N/A | 2023-10-31 |
| Unknown | Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification Diabetes type2 | Phase 4 | 2019-05-01 |
| Unknown | A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With T Type 2 Diabetes Mellitus, Peritoneal Dialysis | Phase 4 | 2017-06-03 |